BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4194447)

  • 21. [Fluctuations of the long-acting thyroid stimulator (LATS) concentration in the blood and its significance in hyperthyroidism].
    Noguchi A; Kurihara H; Ozeki Y; Sato S
    Nihon Rinsho; 1967 Oct; 25(8):1723-32. PubMed ID: 5626106
    [No Abstract]   [Full Text] [Related]  

  • 22. [Etiology of Basedow's disease, with special reference to LATS].
    Nagata K
    Naika Hokan; 1969 Jul; 16(7):297-317. PubMed ID: 4901097
    [No Abstract]   [Full Text] [Related]  

  • 23. Observations on the nature and significance of the long-acting thyroid stimulator.
    Brown J; Dorrington KJ; Ensor J; Smith BR; Munro DS
    Proc R Soc Med; 1968 Dec; 61(12):1301-2. PubMed ID: 4177972
    [No Abstract]   [Full Text] [Related]  

  • 24. LATS protector, the human thyroid stimulator.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
    [No Abstract]   [Full Text] [Related]  

  • 25. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
    zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
    Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
    [No Abstract]   [Full Text] [Related]  

  • 26. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
    Lamberg BA; Gordin A
    Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
    [No Abstract]   [Full Text] [Related]  

  • 27. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Med Klin; 1966 Dec; 61(52):2062-3. PubMed ID: 5999210
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pitfalls in the biological demonstration of the "long acting thyroid stimulator" (LATS)].
    Mertz DP; Stelzer M
    Schweiz Med Wochenschr; 1968 Sep; 98(38):1471-5. PubMed ID: 5680881
    [No Abstract]   [Full Text] [Related]  

  • 29. [Recent advances in studies on LATS].
    Kumahara U; Miyai K; Fukuchi M
    Saishin Igaku; 1967 Jul; 22(7):1373-80. PubMed ID: 4171439
    [No Abstract]   [Full Text] [Related]  

  • 30. [Significance of long-acting thyroid stimulator. Reflections on the 1st series of results].
    Tourneur R; Letonturier P; Sénécal P
    Minerva Med; 1974 Mar; 65(19):995-8. PubMed ID: 4406464
    [No Abstract]   [Full Text] [Related]  

  • 31. [Significance of the "long acting thyroid stimulator"].
    Tourneur R; Letonturier P; Sénécal P
    Cah Med; 1974 Mar; 15(3):121-3. PubMed ID: 4479615
    [No Abstract]   [Full Text] [Related]  

  • 32. [LATS and thyroid antibody level in the blood in Basedow's disease].
    Földes J; Takó J; Bános C; Gesztesi E; Varga I
    Orv Hetil; 1968 Aug; 109(33):1799-804. PubMed ID: 5714825
    [No Abstract]   [Full Text] [Related]  

  • 33. [The etiopathogenic role of long-acting thyroid stimulator in thyrotoxicosis].
    Papazov G; Milanov S; Platonova E
    Vutr Boles; 1972; 11(2):59-62. PubMed ID: 4679953
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos.
    Friis T
    Dan Med Bull; 1969 Nov; 16(10):294-304. PubMed ID: 5392781
    [No Abstract]   [Full Text] [Related]  

  • 35. [Etiology of hyperthyroidism].
    Lemarchand-Béraud T; Vannotti A; Griessen M
    Schweiz Med Wochenschr; 1967 Oct; 97(41):1342-52. PubMed ID: 5631864
    [No Abstract]   [Full Text] [Related]  

  • 36. Reduced sensitivity of the thyroid to thyrotrophic hormone and LATS following treatment with antimicrosomal antibodies.
    Földes J; Takó J; Bános C; Gesztesi E; Juhász J
    Acta Endocrinol (Copenh); 1973 Dec; 74(4):675-84. PubMed ID: 4800904
    [No Abstract]   [Full Text] [Related]  

  • 37. [L.A.T.S. activity during hyperthyroidism. Apropos of 143 cases of Basedow's disease].
    Letonturier P; Tourneur R; Sénécal P
    Ann Med Interne (Paris); 1974 May; 125(5):463-7. PubMed ID: 4140703
    [No Abstract]   [Full Text] [Related]  

  • 38. Evolution of the concept of the pathogenesis of toxic diffuse goitre (Graves' disease) and an assessment of the long-acting thyroid stimulator (L.A.T.S.).
    Hassan HA
    J Egypt Med Assoc; 1978; 61(1-2):111-20. PubMed ID: 583050
    [No Abstract]   [Full Text] [Related]  

  • 39. [TSH and LATS].
    Ochi Y; Hachiya T; Shiomi K; Yoshimura M; Miyazaki T
    Saishin Igaku; 1972 May; 27(5):853-61. PubMed ID: 4339218
    [No Abstract]   [Full Text] [Related]  

  • 40. Failure to produce experimental autoimmune thyrotoxicosis in rabbits immunized with thyroidal microsomes.
    Wall JR; Good BF; Hetzel BS
    Aust J Exp Biol Med Sci; 1973 Oct; 51(5):703-6. PubMed ID: 4787506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.